These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 36658582)
1. Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis. Amrutkar M; Berg K; Balto A; Skilbrei MG; Finstadsveen AV; Aasrum M; Gladhaug IP; Verbeke CS Cancer Cell Int; 2023 Jan; 23(1):9. PubMed ID: 36658582 [TBL] [Abstract][Full Text] [Related]
2. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372 [TBL] [Abstract][Full Text] [Related]
3. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
4. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203 [TBL] [Abstract][Full Text] [Related]
5. CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming. Lu X; Wu Y; Cao R; Yu X; Gong J Anim Cells Syst (Seoul); 2022; 26(4):148-157. PubMed ID: 36046033 [TBL] [Abstract][Full Text] [Related]
6. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594 [TBL] [Abstract][Full Text] [Related]
7. Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing. Amrutkar M; Vethe NT; Verbeke CS; Aasrum M; Finstadsveen AV; Sántha P; Gladhaug IP Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287390 [TBL] [Abstract][Full Text] [Related]
8. Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome. Minz AP; Mohapatra D; Dutta M; Sethi M; Parida D; Mohapatra AP; Mishra S; Kar S; Sasmal PK; Senapati S Cancer Immunol Immunother; 2023 Dec; 72(12):4261-4278. PubMed ID: 37926727 [TBL] [Abstract][Full Text] [Related]
9. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer. Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902 [TBL] [Abstract][Full Text] [Related]
10. Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression. Chong YP; Peter EP; Lee FJM; Chan CM; Chai S; Ling LPC; Tan EL; Ng SH; Masamune A; Ghafar SAA; Ismail N; Ho KL Sci Rep; 2022 Jul; 12(1):12315. PubMed ID: 35853996 [TBL] [Abstract][Full Text] [Related]
11. Positive feedback in Cav-1-ROS signalling in PSCs mediates metabolic coupling between PSCs and tumour cells. Shao S; Qin T; Qian W; Yue Y; Xiao Y; Li X; Zhang D; Wang Z; Ma Q; Lei J J Cell Mol Med; 2020 Aug; 24(16):9397-9408. PubMed ID: 32633891 [TBL] [Abstract][Full Text] [Related]
12. Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor. Amrutkar M; Larsen EK; Aasrum M; Finstadsveen AV; Andresen PA; Verbeke CS; Gladhaug IP Cells; 2020 Jan; 9(1):. PubMed ID: 31963309 [TBL] [Abstract][Full Text] [Related]
13. Cellular context-dependent interaction between cancer and stellate cells in hetero-type multicellular spheroids of pancreatic tumor. Nam S; Khawar IA; Park JK; Chang S; Kuh HJ Biochem Biophys Res Commun; 2019 Jul; 515(1):183-189. PubMed ID: 31133378 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells. Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757 [TBL] [Abstract][Full Text] [Related]
15. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification. Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341 [TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs. Zhao B; Qin C; Li Z; Wang Y; Li T; Cao H; Yang X; Li T; Wang W Cancer Cell Int; 2022 Dec; 22(1):374. PubMed ID: 36457017 [TBL] [Abstract][Full Text] [Related]
17. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis. Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. Hering J; Garrean S; Dekoj TR; Razzak A; Saied A; Trevino J; Babcock TA; Espat NJ Ann Surg Oncol; 2007 Dec; 14(12):3620-8. PubMed ID: 17896154 [TBL] [Abstract][Full Text] [Related]
20. Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism. Fujiwara-Tani R; Sasaki T; Takagi T; Mori S; Kishi S; Nishiguchi Y; Ohmori H; Fujii K; Kuniyasu H Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]